Effective but Underprescribed: HIV Prevention Meds Aren’t Reaching Enough People
PrEP has been available for more than a decade, but billing mistakes, lack of awareness, and lingering stigma keep many people from getting the lifesaving HIV prevention medication.
What the Health? From KFF Health News: HHS Gets Funding, But How Will Trump Spend It?
Congress has passed — and President Trump has signed — the annual spending bill for the Department of Health and Human Services. But it’s unclear whether the administration will spend the money as Congress directed. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss that story and more. Also this week, Rovner interviews KFF Health News’ Renuka Rayasam about a new reporting project, “Priced Out.”
Poison at Play: Unsafe Levels of Lead Found in Half of New Orleans Playgrounds
Verite News’ reporters tested soil in more than 80 playgrounds for lead contamination. Even in trace amounts, lead exposure in children can result in lower IQs, learning challenges, and behavioral issues.
Listen: Many Tents Are Gone, but Washington’s Homeless — And Their Health Problems — Aren’t
Sweeps of encampments scatter homeless people, as medications are tossed and street medicine providers scramble to reconnect with their patients. KFF Health News senior correspondent Angela Hart discusses the aftermath on the Jan. 28 edition of WAMU’s “Health Hub.”
NIH Grant Disruptions Slow Down Breast Cancer Research
The Trump administration has made the future of federal funding for cancer research uncertain. At one groundbreaking breast cancer research lab, work that could save lives has slowed significantly.
Trump’s Covid Views Don’t Track With Reality That Recent Studies Suggest
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
This Teen Never Got His Day in Vaccine Court. His Former Lawyer Now Advises RFK on Its Overhaul.
The federal government’s Vaccine Injury Compensation Program was supposed to help patients with their medical bills while protecting vaccine supply. But allies of Health and Human Services Secretary Robert F. Kennedy Jr. are routinely transferring cases from that program to launch lawsuits against drugmakers.
Trump Policies at Odds With Emerging Understanding of Covid’s Long-Term Harm
Studies increasingly offer insights into the health risks and burdens faced by people who have had covid infections. Meanwhile, the Trump administration has narrowed covid vaccine recommendations and cut research.
Políticas del gobierno chocan con el conocimiento emergente sobre los daños a largo plazo de covid
Estos hallazgos generan nuevas preocupaciones sobre las políticas relacionadas con covid durante la administración Trump, según investigadores.
What the Health? From KFF Health News: Health Spending Is Moving in Congress
Lawmakers appear on the brink of passing a spending bill for the Department of Health and Human Services and a bipartisan health policy bill delayed for over a year. But the outlook is bleaker for the health care outline released by President Trump last week. Sandhya Raman of CQ Roll Call, Sheryl Gay Stolberg of The New York Times, and Paige Winfield Cunningham of The Washington Post join KFF Health News’ Julie Rovner to discuss those stories and more. Also this week, Rovner interviews oncologist and bioethicist Ezekiel Emanuel to discuss his new book, “Eat Your Ice Cream.”
As US Is Poised To Lose Measles-Free Status, RFK Jr.’s New CDC Deputy Downplays Its Significance
Measles is at a 30-year high in the U.S., but technicalities may stave off the loss of the nation’s measles elimination status.
Medicaid Tries New Approach With Sickle Cell: Companies Get Paid Only if Costly Gene Therapies Work
The government is using sickle cell treatments to test a new strategy: paying only if the therapies benefit patients. With more expensive treatments on the horizon, the program — created by the Biden administration and continued under President Trump — could help Medicaid save money and treat more patients.
Los pagos de Medicaid por el tratamiento de la anemia falciforme dependerán de su éxito
Actualmente hay dos terapias génicas aprobadas por la FDA, con costos de $2,2 millones por paciente en un caso y $3,1 millones en el otro, sin incluir el gasto de la hospitalización prolongada que requieren.
Estados Unidos podría perder su estatus de país libre de sarampión
Esto marca un cambio importante desde que Estados Unidos eliminara el sarampión en el año 2000. Hasta ahora, el virus aparecía de manera esporádica, con personas infectadas en el extranjero, pero rara vez provocaba brotes locales debido a las altas tasas de vacunación.
Physician-Journalist Shines Light on Measles Upsurge and New GLP-1 Study
KFF Health News’ editor-at-large for public health recently took to the airwaves to discuss topical stories. Here’s a collection of her appearances.
How Is Your County Spending Opioid Settlement Cash? Our New Tool Follows the Money.
Lifesaving or wasteful? Opinion is divided on the ways local communities are using opioid settlement funds. Survivors of the overdose crisis and families who’ve lost loved ones to it are raising alarms about what some perceive as wasteful spending.
Martha Santana-Chin, hija de inmigrantes mexicanos, creció con Medi-Cal, la versión californiana de Medicaid, el programa de atención médica administrado por el gobierno para personas con bajos ingresos y discapacidades.
GOP Cuts Will Cripple Medicaid Enrollment, Warns CEO of Largest Public Health Plan
Martha Santana-Chin, a daughter of Mexican immigrants, last year took the helm of L.A. Care, the nation’s largest publicly operated health plan. She warns that looming federal cuts will push up to 650,000 people off L.A. Care’s Medicaid rolls by the end of 2028.
Vaccines Are Helping Older People More Than We Knew
Many shots seem to have “off-target” benefits, such as lowering the risk of dementia, studies have found.
Las vacunas ayudan a las personas mayores más de lo que se pensaba
En el lenguaje médico, se conocen como “beneficios indirectos”: efectos positivos que van más allá de prevenir la enfermedad para la que esas vacunas fueron diseñadas.
